Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
American Journal of Clinical Dermatology|November 13, 2001
Actinic keratosis. Current treatment optionsE W Jeffes, E H TangClinical and Experimental Dermatology|March 1, 1989
Adjuvant therapy of bullous pemphigoid with dapsoneE W Jeffes, A R AhmedJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1976
Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cellsE W Jeffes, G A GrangerJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctesE W Jeffes, G A GrangerDermatologic Clinics|October 1, 1995
Methotrexate and other chemotherapeutic agents used to treat psoriasisE W Jeffes, G D WeinsteinJournal of Clinical Immunology|September 1, 1984
Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysisE W Jeffes, R P Kaplan, A R AhmedThe American Journal of Dermatopathology|October 1, 1992
Verruciform xanthoma of the ear with coexisting epidermal dysplasiaJ L Jensen, S Y Liao, E W JeffesThe Journal of Investigative Dermatology|August 1, 1990
Recombinant human cytokines stimulate neutrophil adherence to IgG autoantibody-treated epithelial basement membranesW R Gammon, J D Hendrix, K Mangum, et al.Journal of Clinical Immunology|January 1, 1984
Lymphotoxin detected in the blister fluid of bullous pemphigoid patientsE W Jeffes, R S Yamamoto, A R Ahmed, et al.Lymphokine Research|January 1, 1987
Human alpha lymphotoxin (LT): studies examining the mechanism(s) of LT-induced inflammation and tumor destruction in vivoE W Jeffes, B J Averbook, T R Ulich, et al.Pageof 4